jueves, 14 de julio de 2016

NIH expands investment in HIV cure research | National Institutes of Health (NIH)

NIH expands investment in HIV cure research | National Institutes of Health (NIH)

National Institutes of Health (NIH) - Turning Discovery into Health



Institute/Center

Contact



NIH expands investment in HIV cure research

Six research teams to lead collaborative investigations worldwide.
The National Institutes of Health has awarded approximately $30 million in annual funding over the next five years to six research collaborations working to advance basic medical science toward an HIV cure. The awards comprise the second iteration of the Martin Delaney Collaboratory: Towards an HIV-1 Cure program and are a part of President Barack Obama’s pledge to invest in HIV cure research. The research program is supported by the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute on Drug Abuse, the National Institute of Mental Health, and the National Institute of Neurological Disorders and Stroke, all part of the NIH.
“A simple, safe and scalable cure for HIV would accelerate progress toward ending the HIV/AIDS pandemic.”
Anthony S. Fauci, M.D., Director, NIAID
“The two greatest challenges remaining in HIV/AIDS research are finding a cure and developing a safe and effective preventive vaccine. This year, NIAID has made significant investments toward both of these critical goals,” said NIAID Director Anthony S. Fauci, M.D.
“A simple, safe and scalable cure for HIV would accelerate progress toward ending the HIV/AIDS pandemic,” he added. “Through the leadership of talented investigators with a diversity of expertise, the Martin Delaney Collaboratory program will accelerate progress in this key research endeavor.” Research toward a cure also is an overarching priority for the NIH HIV/AIDS research program.
While advances in antiretroviral therapy (ART) have transformed HIV infection from a life-threatening disease to a manageable, chronic condition, a cure remains elusive. In 2010, NIAID established the Martin Delaney Collaboratory program in honor of the late HIV/AIDSactivist Martin Delaney, a skilled and passionate advocate for cure research who served on the NIAID AIDS Research Advisory Committee.
The collaboratory program supports international HIV cure research networks and encourages collaborative efforts to address the multifaceted puzzle of curing HIV. While the scientific community knows far more about HIV/AIDS since the disease was first reported more than 35 years ago, a cure remains elusive in large part because HIV has the ability to establish a reservoir in the body by inserting its genetic material into that of immune cells that have a long lifespan. The virus remains in these cells in a latent state, invisible to the immune system and to anti-HIV therapies. ART only targets HIV when it is actively replicating, so the treatment can never clear the cells containing the latent, non-replicating virus from an infected individual’s blood and tissues. If an individual discontinues ART, the virus emerges from these cells and reconstitutes a widespread infection. Tackling this problem therefore requires experts with expansive knowledge of HIV pathology, genetics and the immune system.
Since the first three Martin Delaney Collaboratory grants were awarded, the program has evolved to include more grants and industry partners with an increased emphasis on translational and clinical research. NIAID funded highly meritorious project applications that demonstrated elegant experimental design, leveraged investigators’ expertise in the related fields of vaccine and cancer immunotherapy research and made use of public-private partnerships to ensure access to innovative new approaches.
The new collaboratory projects will launch novel investigations into HIV cure strategies that include immunotherapy, therapeutic vaccines and gene modification. The awardees will utilize a variety of experimental techniques to draw HIV out of its reservoir and eliminate the virus.  These strategies include testing latency-reversing agents alone and in combination, genetically engineering immune cells to better target latently infected cells, and optimizing combinations of anti-HIV antibodies and other immunotherapeutic drugs. While each of the principal investigators’ institutions are located in the United States, the collaborative projects will involve laboratories on five continents, including Africa, the first time that continent has been part of an international HIV cure research program.

The recipients are as follows:

George Washington University, Washington, D.C.
Project Title: BELIEVE: Bench to Bed Enhanced Lymphoctye Infusions to Engineer Viral Eradication
Grant: 1 UM1AI26617-01
Award: $5,715,517
University of California, San Francisco
Project Title: Delaney AIDS Research Enterprise to Cure HIV
Grant: 1 UM1AI26611-01
Award: $5,547,114
Fred Hutchinson Cancer Research Center, Seattle
Project Title: defeatHIV: Cell and Gene Therapy for HIV Cure
Grant: 1 UM1AI26623-01
Award: $4,714,991
Wistar Institute, Philadelphia
Project Title: BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
Grant: 1 UM1AI26620-01
Award: $4,589,036
Beth Israel Deaconess Medical Center, Boston
Project Title: Combined Immunologic Approaches to Cure HIV-1
Grant: 1 UM1AI26603-01
Award: $4,630,463
University of North Carolina, Chapel Hill
Project Title: Collaboratory of AIDS Researchers for Eradication (CARE)
Grant: 1 UM1AI126619-01
Award: $4,592,950
NIAID conducts and supports research — at NIH, throughout the United States, and worldwide — to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH…Turning Discovery Into Health®

3 comentarios:

  1. How to Join Illuminati and become rich and famous
    How to Join Illuminati in UK
    How to Join Illuminati in Kenya
    How to Join Illuminati in USA
    How to Join Illuminati in South Africa
    How to Join Illuminati in India
    How to Join Illuminati in Pakistan
    How to The Illuminati in Australia
    How to Join Illuminati in Malaysia
    How to Join Illuminati in Ghana
    How to Join Illuminati in Nairobi
    How to Join Illuminati in Zambia
    How to Join Illuminati in Nigeria HOW to Join Illuminati in Namibia HOW to Join Illuminati in Botswana HOW to Join Illuminati in Europe
    How to Join Illuminati for Wealth
    How to Join Illuminati and become Rich
    How to Join Illuminati for Fame and powers We Welcome any one how make up his hart desire to join the society, you must have good reputation to approve,E.g,politicians,pastors,business man or woman,celebrities,professional teacher,or working class,your talent must be connected to it as wall in other to welcome you to the great illuminati brotherhood society,after the due coronation to make you a full member,them it we enable us empower you with more wealth,with the POT of riches that we be given to you as well,what of billions of USD dollars,after them we back it up with powers,once we make you a full member,them you knows what we are talking about,that is the major reason why illuminati is only main for people who have good reputation to shows as well,any interested one should Email us on,illuminatiworldoder664@gmail.com for immediate answer call mr timothy on +2349035324155 or whatsapp him,again you must be above 21 years old.

    ResponderEliminar
    Respuestas
    1. Hello. viewer am here to share my testimony on how I finally join the Illuminati hood and became rich , i am marry by name 45 years old from palm coast florida usa, I tried all my possible best to become a member of the hood but I was scam several times , before I finally come across a testimony on net so I contacted the agent , I was so afraid that he will ask me for lot of money before I can join the hood but to my greatest surprise he only ask me to obtain the pot of riches which I did and today, am so happy to say to the world that am one of the richest by having the sum of $ 360 millions dollars in my personal account as a new member in Africa and am also known all over the world with the business given to me by the Illuminati and also have power to do that which I want . .. ... I know so many people may be on my lane also looking for help .You can get in touch with our grand master. by E-mail; illuminati666official@gmail.com or WhatsApp +1(863)693-9739 remember only serious people should contact us and no going back 6.6.6....

      Eliminar
  2. Hello. viewer am here to share my testimony on how I finally join the Illuminati hood and became rich , i am marry by name 45 years old from palm coast florida usa, I tried all my possible best to become a member of the hood but I was scam several times , before I finally come across a testimony on net so I contacted the agent , I was so afraid that he will ask me for lot of money before I can join the hood but to my greatest surprise he only ask me to obtain the pot of riches which I did and today, am so happy to say to the world that am one of the richest by having the sum of $ 360 millions dollars in my personal account as a new member in Africa and am also known all over the world with the business given to me by the Illuminati and also have power to do that which I want . .. ... I know so many people may be on my lane also looking for help .You can get in touch with our grand master. by E-mail; illuminati666official@gmail.com or WhatsApp +1(863)693-9739 remember only serious people should contact us and no going back 6.6.6....

    ResponderEliminar